Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 2369 - 2376 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC6925 | (RS)-APICA |
|
Rigidified analog of MPPG; selective group II metabotropic glutamate receptor antagonist (IC<sub>50</sub> = 30 <span class='symbol'>μ</span>M) with no significant effect on group I and III mGlu receptors at concentrations up to 1 mM. Increases extracellular glutamate concentrations and possesses unusual inverse agonist-like action.
|
|
| BCC6926 | (RS)-AMPA hydrobromide |
|
More water soluble hydrobromide salt of (<em>RS</em>)-AMPA.
|
|
| BCC6927 | (-)-Lobeline hydrochloride |
|
High affinity, partial agonist with a Ki value of 4.4 nM in rat brain.
|
|
| BCC6928 | (+)-SK&F 10047 hydrochloride |
|
Prototypical <span class='symbol'>σ</span><sub>1</sub> receptor agonist. Behaviorally active in animal models of memory and stress.
|
|
| BCC6929 | (R)-(+)-8-Hydroxy-DPAT hydrobromide |
|
Full 5-HT<sub>1A</sub> serotonin receptor agonist; more active enantiomer. Reduces hippocampal 5-HT levels following systemic administration in rats <em>in vivo</em>. More active enantiomer of 8-Hydroxy-DPAT hydrobromide. 7-Hydroxy-DPAT hydrobromide also available.
|
|
| BCC6930 | SKF 89976A hydrochloride |
|
A potent GABA uptake inhibitor, selective for GAT-1 (IC<sub>50</sub> values are 0.13, 550, 944 and 7210 <span class='symbol'>μ</span>M for hGAT-1, rGAT-2, hGAT-3 and hBGT-1 respectively). Inhibits transport current competitively (K<sub>i</sub> = 7 <span class='symbol'>μ</span>M) and transmitter-gated current non-competitively (K<sub>i</sub> = 0.03 nM). Able to pass the blood-brain barrier after systemic administration and is active <em>in vivo</em>.
|
|
| BCC6931 | CFM-2 |
|
Novel, selective non-competitive AMPA antagonist. Highly potent, long-acting anticonvulsant.
|
|
| BCC6932 | Iberiotoxin |
|
Selective blocker of the big conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel.
|
|